Replies to post #342 on NewLink Genetics Corporation (NLNK)

[magnumbp]

Merck sold their vaccine division in 2013 which means they cut back their development efforts. They still have the means to help with the mass production of Newlinks VSV-EBOV. I think its interesting that there is a tie with GSK, since there was chatter last week that said Newlink and GSK may join forces for a more effective solution.